Greenwald Rena, Lyashchenko Olena, Esfandiari Javan, Miller Michele, Mikota Susan, Olsen John H, Ball Ray, Dumonceaux Genevieve, Schmitt Dennis, Moller Torsten, Payeur Janet B, Harris Beth, Sofranko Denise, Waters W Ray, Lyashchenko Konstantin P
Chembio Diagnostic Systems, Inc, Medford, New York 11763, USA.
Clin Vaccine Immunol. 2009 May;16(5):605-12. doi: 10.1128/CVI.00038-09. Epub 2009 Mar 4.
Tuberculosis (TB) in elephants is a reemerging zoonotic disease caused primarily by Mycobacterium tuberculosis. Current methods for screening and diagnosis rely on trunk wash culture, which has serious limitations due to low test sensitivity, slow turnaround time, and variable sample quality. Innovative and more efficient diagnostic tools are urgently needed. We describe three novel serologic techniques, the ElephantTB Stat-Pak kit, multiantigen print immunoassay, and dual-path platform VetTB test, for rapid antibody detection in elephants. The study was performed with serum samples from 236 captive African and Asian elephants from 53 different locations in the United States and Europe. The elephants were divided into three groups based on disease status and history of exposure: (i) 26 animals with culture-confirmed TB due to M. tuberculosis or Mycobacterium bovis, (ii) 63 exposed elephants from known-infected herds that had never produced a culture-positive result from trunk wash samples, and (iii) 147 elephants without clinical symptoms suggestive of TB, with consistently negative trunk wash culture results, and with no history of potential exposure to TB in the past 5 years. Elephants with culture-confirmed TB and a proportion of exposed but trunk wash culture-negative elephants produced robust antibody responses to multiple antigens of M. tuberculosis, with seroconversions detectable years before TB-positive cultures were obtained from trunk wash specimens. ESAT-6 and CFP10 proteins were immunodominant antigens recognized by elephant antibodies during disease. The serologic assays demonstrated 100% sensitivity and 95 to 100% specificity. Rapid and accurate antibody tests to identify infected elephants will likely allow earlier and more efficient treatment, thus limiting transmission of infection to other susceptible animals and to humans.
大象结核病是一种再度出现的人畜共患病,主要由结核分枝杆菌引起。目前的筛查和诊断方法依赖于象鼻冲洗液培养,但由于检测灵敏度低、周转时间长和样本质量参差不齐,该方法存在严重局限性。因此,迫切需要创新且更高效的诊断工具。我们描述了三种新型血清学技术,即大象结核病快速检测试剂盒、多抗原印迹免疫测定法和双路径平台兽医结核病检测法,用于快速检测大象体内的抗体。本研究使用了来自美国和欧洲53个不同地点的236头圈养非洲象和亚洲象的血清样本。这些大象根据疾病状况和接触史分为三组:(i)26头因结核分枝杆菌或牛分枝杆菌导致培养确诊结核病的动物;(ii)63头来自已知感染群体的接触大象,其象鼻冲洗样本培养结果从未呈阳性;(iii)147头无结核病临床症状、象鼻冲洗培养结果始终为阴性且在过去5年无结核病潜在接触史的大象。培养确诊结核病的大象以及一部分接触但象鼻冲洗培养阴性的大象对结核分枝杆菌的多种抗原产生了强烈的抗体反应,在从象鼻冲洗样本获得结核病阳性培养结果的数年前就能检测到血清转化。ESAT-6和CFP10蛋白是疾病期间大象抗体识别的免疫优势抗原。血清学检测显示灵敏度为100%,特异性为95%至100%。快速准确的抗体检测来识别受感染的大象可能会实现更早、更有效的治疗,从而限制感染向其他易感动物和人类的传播。